Caricamento...
SUN-418 An Uncommon Case of Anti-PD1 Agent Induced Secondary Adrenal Insufficiency
Introduction - Nivolumab is a monoclonal anti-programmed cell death receptor 1(PD1) antibody approved for the treatment of unresectable or metastatic melanoma and is known to be associated with a wide spectrum of endocrinologic derangements. The objective of this report is to describe a case of symp...
Salvato in:
| Pubblicato in: | J Endocr Soc |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Endocrine Society
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553168/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-418 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|